October 15th, 2022
This conference has already taken place.
Description
New pharmacology treatments and procedures are increasingly being done for therapies on the heart. These new treatment therapies are being utilized in cardio-oncology, electrophysiology, heart failure, interventional cardiology, preventive cardiology, and sometimes multiple therapies or clinical areas are partnering together in diagnosing and treating heart ailments.
Emphasis will be on understanding clinical history and findings indicative of cardiac syncope; cardiac conduction system and mechanisms of arrhythmias; antiarrhythmic drug selection in the management of atrial fibrillation; comparing and contrasting different types of permanent pacing; identifying criteria diagnosis for inherited arrhythmias; indications for anticoagulation and options available; indications and treatment options for left atrial appendage occlusion closure devices, septal defects, myocardial infractions and chemo prevention effects on the heart.
This course will provide physicians, nurses, and allied health professionals with innovative information regarding the most current management of heart disease and related disorders.
Agenda:
7:30 am Registration and breakfast
8:00 Welcome
Pamela Gardner, DO and Mahmoud Houmsse, MD, FACC, FHRS
8:05 Atrial Septal Defect
Zane W.M. Dean, MD
8:25 Syncope-Utilization of Wearable Defibrillator
Alexander Wallner, MD
8:45 Anticoagulation in Atrial Fibrillation: Selection of the most appropriate drug
Mike Boyd, PharmD
9:05 Syncope
Joanna Keefe, APRN, CNP. MS
9:25 COVID…Cardiac Chaos
Vahid Tavakoli, MD, PhD, RPVI
9:45 Diet Misconception – Should We Veto Keto
Paige Wagner, MPH, RDN, LD
10:05 Rate vs. Rhythm Control in Atrial Fibrillation
Mahmoud Houmsse, MD, FACC, FHRS
10:25 Break
10:40 Cardio Oncology
Daniel Addison, MD
11:00 Left Arterial Appendage Closure Device-Defining the Who's and How's
Mahmood Houmsse, MD, FACC, FHRS
11:20 TEE evaluation and management post LAA occlusion device
Mary Breckenridge, MD
11:40 Aortic Stenosis and Treatment Options
Natalie Lammers, PA-C
12:00 pm Sex and Exercise After Post MI
Masroor Abro, MD
12:20 Adjournment
Pamela Gardner, DO and Mahmoud Houmsse, MD, FACC, FHRS
For pricing information, see pricing tab below.
Dates and Times
Start: 10/15/2022 12:00 AM
End: 10/15/2022 12:00 AM
Objectives
At the conclusion of this continuing medical education activity participants will be able to:
1. Discuss work up of atrial septal defect and identify the appropriate indication for closure of atrial septal defect;
2. Discuss the work-up and management of syncope as well as the appropriate referral procedure;
3. Identify the most appropriate oral anticoagulation (OAC) therapy in patients with non-valvular atrial fibrillation;
4. Identify patients that are candidate for wearable defibrillator;
5. Review the impact of COVID-19 on cardiac morbidity and the COVID-19 vaccine on cardiac function;
6. Identify the best diet to enhance weight loss;
7. Review appropriate rhythm control strategy;
8. Discuss impact of cancer therapy of cardiac function and development of cardiomyopathy;
9. Review the appropriate candidates for TAVR and post-TAVR evaluation and management;
Pricing
| Tier | Price |
|---|---|
| Physiician | $0.00 |
| Nurse | $0.00 |
| Healthcare Professional | $0.00 |
Speakers
Location
The Ohio State University Lima Branch
Reed Hall
4240 Campus Drive
Lima, OH 45804
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.